BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 12296852)

  • 1. C5a is important in the tubulointerstitial component of experimental immune complex glomerulonephritis.
    Welch TR; Frenzke M; Witte D; Davis AE
    Clin Exp Immunol; 2002 Oct; 130(1):43-8. PubMed ID: 12296852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of a role for local complement expression in a murine model of progressive glomerulonephritis.
    Welch TR; Frenzke M; Witte D
    Pediatr Res; 2000 Aug; 48(2):200-5. PubMed ID: 10926295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C3 is central to the interstitial component of experimental immune complex glomerulonephritis.
    Welch TR; Blystone LW
    Clin Immunol; 2005 Apr; 115(1):80-4. PubMed ID: 15870025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune complex glomerulonephritis following bone marrow transplantation in C3 deficient mice.
    Welch TR; Blystone LW
    PLoS One; 2008 Oct; 3(10):e3334. PubMed ID: 18836527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced expression of complement C5a receptor mRNA in human diseased kidney assessed by in situ hybridization.
    Abe K; Miyazaki M; Koji T; Furusu A; Nakamura-Kurashige T; Nishino T; Ozono Y; Harada T; Sakai H; Kohno S
    Kidney Int; 2001 Jul; 60(1):137-46. PubMed ID: 11422745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shift of C3 deposition from localization in the glomerulus into the tubulo-interstitial compartment in the absence of secreted IgM in immune complex glomerulonephritis.
    Vaculik C; Rüger BM; Yanagida G; Hollemann D; Soleiman A; Losert UM; Chen J; Fischer MB
    Clin Exp Immunol; 2008 Jan; 151(1):146-54. PubMed ID: 17991287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune complex induced glomerular lesions in C5 sufficient and deficient mice.
    Falk RJ; Jennette JC
    Kidney Int; 1986 Nov; 30(5):678-86. PubMed ID: 2946891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The atypical chemokine receptor 2 limits renal inflammation and fibrosis in murine progressive immune complex glomerulonephritis.
    Bideak A; Blaut A; Hoppe JM; Müller MB; Federico G; Eltrich N; Gröne HJ; Locati M; Vielhauer V
    Kidney Int; 2018 Apr; 93(4):826-841. PubMed ID: 29395335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The C5a receptor has a key role in immune complex glomerulonephritis in complement factor H-deficient mice.
    Alexander JJ; Chaves L; Chang A; Quigg RJ
    Kidney Int; 2012 Nov; 82(9):961-8. PubMed ID: 22832515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct tissue site-specific requirements of mast cells and complement components C3/C5a receptor in IgG immune complex-induced injury of skin and lung.
    Baumann U; Chouchakova N; Gewecke B; Köhl J; Carroll MC; Schmidt RE; Gessner JE
    J Immunol; 2001 Jul; 167(2):1022-7. PubMed ID: 11441111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disruption of the C5a receptor gene fails to protect against experimental allergic encephalomyelitis.
    Reiman R; Gerard C; Campbell IL; Barnum SR
    Eur J Immunol; 2002 Apr; 32(4):1157-63. PubMed ID: 11932923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesangial cell complement receptor 1-related protein y limits complement-dependent neutrophil accumulation in immune complex glomerulonephritis.
    Bao L; Wang Y; Chen P; Sarav M; Haas M; Minto AW; Petkova M; Quigg RJ
    Immunology; 2009 Sep; 128(1 Suppl):e895-904. PubMed ID: 19740350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune complex glomerulonephritis in C4- and C3-deficient mice.
    Quigg RJ; Lim A; Haas M; Alexander JJ; He C; Carroll MC
    Kidney Int; 1998 Feb; 53(2):320-30. PubMed ID: 9461092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement component C3 is not required for full expression of immune complex glomerulonephritis in MRL/lpr mice.
    Sekine H; Reilly CM; Molano ID; Garnier G; Circolo A; Ruiz P; Holers VM; Boackle SA; Gilkeson GS
    J Immunol; 2001 May; 166(10):6444-51. PubMed ID: 11342671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Programmed death 1 and its ligands do not limit experimental foreign antigen-induced immune complex glomerulonephritis.
    Ooi JD; Li M; Kourkoutzelos K; Yagita H; Azuma M; Holdsworth SR; Kitching AR
    Nephrology (Carlton); 2015 Dec; 20(12):892-8. PubMed ID: 26043977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nephropathy associated with sickle cell anemia: an autologous immune complex nephritis. II. Clinicopathologic study of seven patients.
    Pardo V; Strauss J; Kramer H; Ozawa T; McIntosh RM
    Am J Med; 1975 Nov; 59(5):650-9. PubMed ID: 128292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of intrinsic renal cells versus infiltrating cells in glomerular crescent formation.
    Ophascharoensuk V; Pippin JW; Gordon KL; Shankland SJ; Couser WG; Johnson RJ
    Kidney Int; 1998 Aug; 54(2):416-25. PubMed ID: 9690208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interstrain variations in nephritogenicity of heterologous protein in mice.
    Iskandar SS; Jennette JC; Wilkman AS; Becker RL
    Lab Invest; 1982 Mar; 46(3):344-51. PubMed ID: 6460898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decay-accelerating factor but not CD59 limits experimental immune-complex glomerulonephritis.
    Bao L; Haas M; Minto AW; Quigg RJ
    Lab Invest; 2007 Apr; 87(4):357-64. PubMed ID: 17259999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence of a role for C4 in modulating interstitial inflammation in experimental glomerulonephritis.
    Welch TR; Frenzke M; Carroll MC; Witte DP
    Clin Immunol; 2001 Dec; 101(3):366-70. PubMed ID: 11726230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.